SCHEMBL1702738

SCHEMBL1702738

O=C(O)C(Cc1c[nH]c2ccccc12)=NO

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.68
MEN1 O00255 7/20 0.68
KMT2A Q03164 7/20 0.68
SMN1; SMN2 Q16637 3/20 0.68
KDM4E B2RXH2 3/20 0.68
ALDH1A1 P00352 2/20 0.68
HPGD P15428 1/20 0.68
SLC6A2 P23975 1/20 0.60
FNTA P49354 1/20 0.60
FNTB P49356 1/20 0.60
LMNA P02545 2/20 0.56
CYP1A2 P05177 2/20 0.54
PKM P14618 1/20 0.54
CTBP2 P56545 3/20 0.53
CYP3A4 P08684 2/20 0.52
CYP2C19 P33261 1/20 0.52
APAF1 O14727 1/20 0.51
POLB P06746 1/20 0.51
RECQL P46063 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1754977 1.00 MAPT (0.68) MAPTMEN1KMT2ASMN1; SMN2KDM4E
SCHEMBL8433947 0.83 KMT2A (0.61) MAPTMEN1KMT2ASMN1; SMN2KDM4E
SCHEMBL20211099 0.81 MEN1 (0.71) MAPTMEN1KMT2ASMN1; SMN2KDM4E
SCHEMBL7956840 0.81 PKM (0.67) MAPTMEN1KMT2ASMN1; SMN2KDM4E
SCHEMBL8442871 0.81 PKM (0.67) MAPTMEN1KMT2ASMN1; SMN2KDM4E
SCHEMBL7956839 0.81 PKM (0.67) MAPTMEN1KMT2ASMN1; SMN2KDM4E
SCHEMBL29362070 0.81 MEN1 (1.00) MAPTMEN1KMT2ASMN1; SMN2KDM4E
SCHEMBL27763159 0.81 MEN1 (1.00) MAPTMEN1KMT2ASMN1; SMN2KDM4E
SCHEMBL125249 0.81 MEN1 (1.00) MAPTMEN1KMT2ASMN1; SMN2KDM4E
Indole-3-Acetic Acid SCHEMBL26344 0.80 MEN1 (0.75) MAPTMEN1KMT2ASMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1806408-B1 Process for producing amino acid derivatives from hydroxyimino acids AJINOMOTO KK (JP) 2012-04-18 EP claimed
US-8043836-B2 Contacting Citrobacter/Escherichia and/or enzyme with a hydroxyimino acid; for biosynthesis of tryptophan AJINOMOTO CO., INC. (JP) 2011-10-25 US claimed
US-20080193984-A1 Process For Producing Amino Acid Derivative From Hydroxyimino Acid AJINOMOTO CO., INC. (JP) 2008-08-14 US claimed
EP-1806408-A1 PROCESS FOR PRODUCING AMINO ACID DERIVATIVE FROM HYDROXYIMINO ACID Ajinomoto Co., Inc. (JP) 2007-07-11 EP claimed
EP-1806408-B1 Process for producing amino acid derivatives from hydroxyimino acids AJINOMOTO KK (JP) 2012-04-18 EP disclosed
US-8043836-B2 Contacting Citrobacter/Escherichia and/or enzyme with a hydroxyimino acid; for biosynthesis of tryptophan AJINOMOTO CO., INC. (JP) 2011-10-25 US disclosed
US-8043836-B2 Contacting Citrobacter/Escherichia and/or enzyme with a hydroxyimino acid; for biosynthesis of tryptophan AJINOMOTO CO., INC. (JP) 2011-10-25 US disclosed
US-20080193984-A1 Process For Producing Amino Acid Derivative From Hydroxyimino Acid AJINOMOTO CO., INC. (JP) 2008-08-14 US disclosed
US-20080193984-A1 Process For Producing Amino Acid Derivative From Hydroxyimino Acid AJINOMOTO CO., INC. (JP) 2008-08-14 US disclosed
EP-1806408-A1 PROCESS FOR PRODUCING AMINO ACID DERIVATIVE FROM HYDROXYIMINO ACID Ajinomoto Co., Inc. (JP) 2007-07-11 EP disclosed
US-5607934-A PREVENTING AND TREATING DISEASES CAUSED BY SUPEROXIDE RADICALS, NEPHRITIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1997-03-04 US disclosed
US-4194050-A HYDROGENATING OXIMES HAVING AN ALPHA-HYDROGEN USING A RUTHENIUM CATALYST AND A CARBOXYLIC ANHYDRIDE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1980-03-18 US disclosed
US-4137417-A Process for producing an enamide SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1979-01-30 US disclosed